Copiktra (duvelisib capsules - Secura Bio) — Cigna
Small Lymphocytic Lymphoma (SLL)
Initial criteria
- Patient is age ≥ 18 years
- Patient has tried at least one Bruton tyrosine kinase inhibitor (e.g., Imbruvica, Brukinsa, Calquence, Jaypirca)
- Patient has tried at least one B-cell lymphoma 2 inhibitor (e.g., Venclexta)
Approval duration
1 year